Point-of-care testing for C-reactive protein in acute cough presentations
Monday, January 2, 2017
Acute cough is one of the most common illnesses in the UK with an estimated 48 million cases per annum. The majority of these presentations are thought to be of viral aetiology and self-limiting in nature, yet some studies report antibiotic prescription rates of approximately 65% in the UK. Clincians' decision-making process can be influenced by both patient expectations and difficulty in differentiating between viral and bacterial aetiologies by clinical examination alone. Despite warnings about antimicrobial resistance (AMR) from the World Health Organization, clinicians in the UK continue to have high prescription rates for acute cough presentations in comparison to other developed health care systems. This article will consider the feasibility, efficacy, benefits and limitations of using point-of-care testing (POCT) of C-reactive protein (CRP) within primary care in the United Kingdom to help inform management of acute cough.
Subscribe to get full access to the Journal of Paramedic Practice
Thank you for vising the Journal of Paramedic Practice and reading our archive of expert clinical content. If you would like to read more from the only journal dedicated to those working in emergency care, you can start your subscription today for just £48.
Reading the Journal of Paramedic Practice counts towards your professional development
Develop your career
We provide professional information dedicated to paramedics covering training, education and jobs
Get the latest clinical information to ensure you are aware of the latest think and best practice in paramedicne
Already registered? - Sign in here